Mathieu Jeanne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mathieu Jeanne has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Benoit Tavernier
Department of Anesthesiology and Critical Care Medicine, Lille University Hospital, Lille, France; Certified Research Unit 2694 - METRICS: Assessment of Health Technologies and Medical Practices, University of Lille, Lille, France
3 shared publications - Julien De Jonckheere
INSERM CIC-IT 807, University Hospital of Lille, Institut Hippocrate, 2 avenue Oscar Lambret 59037, France
3 shared publications R. Logier
CHU de Lille, Lille, France
3 shared publicationsA. Keribedj
CHU de Lille, Lille, France
2 shared publications- François Dépret
Université Paris Cité, Paris, France
2 shared publications M. Delecroix
CHU de Lille, Lille, France
2 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357922
Time and frequency characteristics of various noninvasive heartbeat sensors
Heart rate and cardiac dynamics can be monitored using several physiological signals, each with its own biophysical basis and signal characteristics. However, while individual properties of electrocardiogram (ECG), phonocardiogram (PCG), seismocardiogram (SCG), photoplethysmogram (PPG), and piezoplethysmogram (PiPG) are documented, systematic cross-modal comparisons remain scarce. This study aims to consolidate both the time and frequency domain features of these widely accessible technologies to provide practical guidelines for signal processing and multimodal integration. We simultaneously recorded ECG, PCG, SCG, PPG, and PiPG under standardized resting conditions and aligned all modalities on the ECG R-peak. Results highlight clear consistencies (e.g., reproducible morphology and spectra for ECG, PPG, and PiPG) as well as higher variability in PCG and SCG due to sensor coupling and anatomical factors. Temporal latencies relative to the ECG confirm known physiological conduction delays, while frequency analysis identifies modality-specific bands: ~ 30 Hz for PCG, 11–14 Hz for SCG, and 1–2 Hz for PPG/PiPG. Bandwidth analysis further emphasizes differences in spectral richness across modalities. By presenting these benchmarks in a unified framework, this work addresses the current gap between isolated characterizations and integrated signal knowledge. The outcome is a reference dataset and interpretation map that can guide filtering strategies, feature extraction, and the design of multimodal cardiac monitoring systems.
- 3 September 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0357922
Open AccessTime and frequency characteristics of various noninvasive heartbeat sensors
Heart rate and cardiac dynamics can be monitored using several physiological signals, each with its own biophysical basis and signal characteristics. However, while individual properties of electrocardiogram (ECG), phonocardiogram (PCG), seismocardiogram (SCG), photoplethysmogram (PPG), and piezoplethysmogram (PiPG) are documented, systematic cross-modal comparisons remain scarce. This study aims to consolidate both the time and frequency domain features of these widely accessible technologies to provide practical guidelines for signal processing and multimodal integration. We simultaneously recorded ECG, PCG, SCG, PPG, and PiPG under standardized resting conditions and aligned all modalities on the ECG R-peak. Results highlight clear consistencies (e.g., reproducible morphology and spectra for ECG, PPG, and PiPG) as well as higher variability in PCG and SCG due to sensor coupling and anatomical factors. Temporal latencies relative to the ECG confirm known physiological conduction delays, while frequency analysis identifies modality-specific bands: ~ 30 Hz for PCG, 11–14 Hz for SCG, and 1–2 Hz for PPG/PiPG. Bandwidth analysis further emphasizes differences in spectral richness across modalities. By presenting these benchmarks in a unified framework, this work addresses the current gap between isolated characterizations and integrated signal knowledge. The outcome is a reference dataset and interpretation map that can guide filtering strategies, feature extraction, and the design of multimodal cardiac monitoring systems.
- 31 July 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (5) , 907-913
Weekly Screening of Circulating Mucorales DNA and Early Treatment in Severely Burned Patients Improves Survival: Real-Life Bi-center Experience in France
Backgound: Invasive fungal diseases, among which includes invasive wound mucormycosis (IWM), are associated with poor outcomes in severely burned patients (SBPs). In recent years, quantitative real-time polymerase chain reaction (PCR) in serum to detect circulating Mucorales DNA (cmDNA) has shown promise for early diagnosis, reducing treatment duration and improving survival. Similarly, recent studies suggest that cmDNA detection enabled earlier diagnosis of IWM in SBPs. This retrospective study aimed to assess the impact of cmDNA-based diagnosis compared to conventional fungal culture on all-cause mortality at 30 and 100 days in SBPs. Methods: We retrospectively analyzed medical records of SBPs with proven or probable IWM over 2 periods, before and after the systematic implementation of cmDNA detection across 2 centers. Results: A total of 37 IWM patients were included. No significant differences were observed in clinical characteristics, treatment regimens, or disease severity between both groups. Our findings indicate that systematic cmDNA detection allowed earlier diagnosis of IWM with a median of −8 days [−16; −4] than mycological culture. The 100-day mortality was reduced from 63.6% to 30.8% (P = .071), and significantly reduced when considering only patients with total body surface area (TBSA) ≥ 30% (P = .047), in the cmDNA group. This earlier detection was associated with early initiation of liposomal amphotericin B-based therapy combined with surgery and may have contributed to the improved outcome. Conclusions: cmDNA screening in targeted high-risk SBPs allows for earlier initiation of specific treatment and appears to improve the prognosis of IWM.
- 31 July 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 81 (5) , 907-913
Weekly Screening of Circulating Mucorales DNA and Early Treatment in Severely Burned Patients Improves Survival: Real-Life Bi-center Experience in France
Backgound: Invasive fungal diseases, among which includes invasive wound mucormycosis (IWM), are associated with poor outcomes in severely burned patients (SBPs). In recent years, quantitative real-time polymerase chain reaction (PCR) in serum to detect circulating Mucorales DNA (cmDNA) has shown promise for early diagnosis, reducing treatment duration and improving survival. Similarly, recent studies suggest that cmDNA detection enabled earlier diagnosis of IWM in SBPs. This retrospective study aimed to assess the impact of cmDNA-based diagnosis compared to conventional fungal culture on all-cause mortality at 30 and 100 days in SBPs. Methods: We retrospectively analyzed medical records of SBPs with proven or probable IWM over 2 periods, before and after the systematic implementation of cmDNA detection across 2 centers. Results: A total of 37 IWM patients were included. No significant differences were observed in clinical characteristics, treatment regimens, or disease severity between both groups. Our findings indicate that systematic cmDNA detection allowed earlier diagnosis of IWM with a median of −8 days [−16; −4] than mycological culture. The 100-day mortality was reduced from 63.6% to 30.8% (P = .071), and significantly reduced when considering only patients with total body surface area (TBSA) ≥ 30% (P = .047), in the cmDNA group. This earlier detection was associated with early initiation of liposomal amphotericin B-based therapy combined with surgery and may have contributed to the improved outcome. Conclusions: cmDNA screening in targeted high-risk SBPs allows for earlier initiation of specific treatment and appears to improve the prognosis of IWM.
- Open Access
- 31 October 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0310627
Heart rate variability analysis for the prediction of pre-arousal during propofol-remifentanil general anaesthesia: A feasibility study
Accidental awareness during general anaesthesia is a major complication. Despite the routine use of continuous electroencephalographic monitoring, accidental awareness during general anaesthesia remains relatively frequent and constitutes a significant additional cost. The prediction of patients’ arousal during general anaesthesia could help preventing accidental awareness and some researchers have suggested that heart rate variability (HRV) analysis contains valuable information about the patient arousal during general anaesthesia. We conducted pilot study to investigate HRV ability to detect patient arousal. RR series and the Bispectral IndexTM (BISTM) were recorded during general anaesthesia. The pre-arousal period T0 was defined as the time at which the BISTM exceeded 60 at the end of surgery. HRV parameters were computed over several time periods before and after T0 and classified as “BISTM0.7. In conclusion, we found that HRV analysis provided encouraging results to predict arousal at the end of general anaesthesia.
- 31 October 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0310627
Open AccessHeart rate variability analysis for the prediction of pre-arousal during propofol-remifentanil general anaesthesia: A feasibility study
Accidental awareness during general anaesthesia is a major complication. Despite the routine use of continuous electroencephalographic monitoring, accidental awareness during general anaesthesia remains relatively frequent and constitutes a significant additional cost. The prediction of patients’ arousal during general anaesthesia could help preventing accidental awareness and some researchers have suggested that heart rate variability (HRV) analysis contains valuable information about the patient arousal during general anaesthesia. We conducted pilot study to investigate HRV ability to detect patient arousal. RR series and the Bispectral IndexTM (BISTM) were recorded during general anaesthesia. The pre-arousal period T0 was defined as the time at which the BISTM exceeded 60 at the end of surgery. HRV parameters were computed over several time periods before and after T0 and classified as “BISTM0.7. In conclusion, we found that HRV analysis provided encouraging results to predict arousal at the end of general anaesthesia.
- 2 May 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 131 (1) , e27-e28
Effect of rapid changes in venous return on the Analgesia Nociception Index™ in anaesthetised patients
- 2 May 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 131 (1) , e27-e28
Effect of rapid changes in venous return on the Analgesia Nociception Index™ in anaesthetised patients
- Open Access
- 25 November 2020
- Published by Springer Nature in Trials
- Vol. 21 (1) , 1-10
The A2B trial, antibiotic prophylaxis for excision-graft surgery in burn patients: a multicenter randomized double-blind study
Background: The indication for antibiotic prophylaxis in burn patients remains highly controversial, with no consensus having been reached. The objective of antibiotic prophylaxis is to reduce the risk of postoperative local and systemic infections. Burn surgery is associated with a high incidence of bacteremia, postoperative infections, and sepsis. However, antibiotic prophylaxis exposes patients to the risk of selecting drug-resistant pathogens as well as to the adverse effects of antibiotics (i.e., Clostridium difficile colitis). The lack of data precludes any strong international recommendations regarding perioperative prophylaxis using systemic antibiotics in this setting. The goal of this project is therefore to determine whether perioperative systemic antibiotic prophylaxis can reduce the incidence of postoperative infections in burn patients. Methods: The A2B trial is a multicenter (10 centers), prospective, randomized, double-blinded, placebo-controlled study. The trial will involve the recruitment of 506 adult burn patients with a total body surface area (TBSA) burn of between 5 and 40% and requiring at least one excision-graft surgery for deep burn injury. Participants will be randomized to receive antibiotic prophylaxis (antibiotic prophylaxis group) or a placebo (control group) 30 min before the incision of the first two surgeries. The primary outcome will be the occurrence of postoperative infections defined as postoperative sepsis and/or surgical site infection and/or graft lysis requiring a new graft within 7 days after surgery. Secondary outcomes will include mortality at day 90 postrandomization, skin graft lysis requiring a new graft procedure, postoperative bacteremia (within 48 h of surgery), postoperative sepsis, postoperative surgical site infection, number of hospitalizations until complete healing (> 95% TBSA), number of hospitalization days living without antibiotic therapy at day 28 and day 90, and multiresistant bacterial colonization or infection at day 28 and day 90. Discussion: The trial aims to provide evidence on the efficacy and safety of antibiotic prophylaxis for excision-graft surgery in burn patients. Trial registration: ClinicalTrials.gov NCT04292054. Registered on 2 March 2020
- 25 November 2020
- Published by Springer Nature in Trials
- Vol. 21 (1) , 1-10
Open AccessThe A2B trial, antibiotic prophylaxis for excision-graft surgery in burn patients: a multicenter randomized double-blind study
Background: The indication for antibiotic prophylaxis in burn patients remains highly controversial, with no consensus having been reached. The objective of antibiotic prophylaxis is to reduce the risk of postoperative local and systemic infections. Burn surgery is associated with a high incidence of bacteremia, postoperative infections, and sepsis. However, antibiotic prophylaxis exposes patients to the risk of selecting drug-resistant pathogens as well as to the adverse effects of antibiotics (i.e., Clostridium difficile colitis). The lack of data precludes any strong international recommendations regarding perioperative prophylaxis using systemic antibiotics in this setting. The goal of this project is therefore to determine whether perioperative systemic antibiotic prophylaxis can reduce the incidence of postoperative infections in burn patients. Methods: The A2B trial is a multicenter (10 centers), prospective, randomized, double-blinded, placebo-controlled study. The trial will involve the recruitment of 506 adult burn patients with a total body surface area (TBSA) burn of between 5 and 40% and requiring at least one excision-graft surgery for deep burn injury. Participants will be randomized to receive antibiotic prophylaxis (antibiotic prophylaxis group) or a placebo (control group) 30 min before the incision of the first two surgeries. The primary outcome will be the occurrence of postoperative infections defined as postoperative sepsis and/or surgical site infection and/or graft lysis requiring a new graft within 7 days after surgery. Secondary outcomes will include mortality at day 90 postrandomization, skin graft lysis requiring a new graft procedure, postoperative bacteremia (within 48 h of surgery), postoperative sepsis, postoperative surgical site infection, number of hospitalizations until complete healing (> 95% TBSA), number of hospitalization days living without antibiotic therapy at day 28 and day 90, and multiresistant bacterial colonization or infection at day 28 and day 90. Discussion: The trial aims to provide evidence on the efficacy and safety of antibiotic prophylaxis for excision-graft surgery in burn patients. Trial registration: ClinicalTrials.gov NCT04292054. Registered on 2 March 2020
- 28 May 2016
- Published by Morressier GmbH
Anaesthesia data warehouse: opportunities for confronting theory and reality
Welcome to the largest platform for early-stage research
- 28 May 2016
- Published by Morressier GmbH
Anaesthesia data warehouse: opportunities for confronting theory and reality
Welcome to the largest platform for early-stage research
- 1 September 2013
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 32 (9) , 636-638
Compte rendu des 19es Journées de la Société francophone pour l’informatique et le monitorage en anesthésie-réanimation (Sfimar)
- 1 September 2013
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 32 (9) , 636-638
Compte rendu des 19es Journées de la Société francophone pour l’informatique et le monitorage en anesthésie-réanimation (Sfimar)
- 1 September 2013
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 32, A267-A268
Mortalité post-opératoire au CHRU de Lille : comparaisons avec l’étude EuSOS
- 1 September 2013
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 32, A267-A268
Mortalité post-opératoire au CHRU de Lille : comparaisons avec l’étude EuSOS
- 1 September 2013
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 32, A348-A349
Utilisation de l’ANI lors de la chirurgie orthopédique : évaluation du bénéfice patient
- 1 September 2013
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 32, A348-A349
Utilisation de l’ANI lors de la chirurgie orthopédique : évaluation du bénéfice patient